ARCHIVES

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

This article is from The Cancer Letter archive.

Vol. 38 No. 14 | April 6, 2012

Download PDF Visit The Full Archive

Related Articles

ACS Increases Funding for Scholar Grants; NCI Posts Interim FY2001 Funding Policy.

December 1, 2000

Elizabeth Miller Will Be Named to Cancer Panel

June 17, 1977

Phase III Vaccine Trial Fails To Improve Overall Survival

October 25, 2013

Jerome Yates Named VP For Research At ACS

February 8, 2002

NCI, Canary Foundation Fund Biomarker Studies In Lung Cancer Of Never-Smokers

May 8, 2009

Bills in House, Senate, would give FDA authority over tobacco products.

June 4, 2004